Ocular neovascularization: a valuable model system (Q35551128)

8 August 2017

1 reference

title

Ocular neovascularization: a valuable model system (English)

1 reference

8 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206773

18 March 2024

author name string

Peter Anthony Campochiaro

series ordinal

1

1 reference

8 August 2017

Sean Francis Hackett

series ordinal

2

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

8 August 2017

29 September 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14528278

full work available at URL

18 March 2024

https://www.nature.com/articles/1206773.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528278

https://www.nature.com/articles/1206773.pdf

18 March 2024

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.ONC.1206773

https://www.nature.com/articles/1206773

18 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.ONC.1206773

18 March 2024

1 reference

8 August 2017

22

1 reference

8 August 2017

42

1 reference

8 August 2017

6537-6548

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206773

8 August 2017

0 references

cites work

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Nitric oxide is proangiogenic in the retina and choroid.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Blockade of nitric-oxide synthase reduces choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Expression of angiopoietin-1, angiopoietin-2, and tie receptors after middle cerebral artery occlusion in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Requirement of vascular integrin alpha v beta 3 for angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Evidence that indomethacin inhibits lymphocyte-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Suppressive Effects of Indomethacin on Thermally Induced Neovascularization of Rabbit Corneas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Intense vascular sprouting from rat femoral vein induced by prostaglandins E1 and E2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

PGE2 and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrier

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Transcriptional activation by tetracyclines in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Systemically expressed soluble Tie2 inhibits intraocular neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Changes in expression of vascular endothelial growth factor and angiopoietin-1 and -2 in the macaque corpus luteum during the menstrual cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Vinca alkaloids: anti-vascular effects in a murine tumour

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

A reevaluation of integrins as regulators of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Astrocytes induce blood–brain barrier properties in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Angiopoietin-1 induces sprouting angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Angiopoietin-1 is an apoptosis survival factor for endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Matrix metalloproteinase-9 contributes to choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Pericyte loss and microaneurysm formation in PDGF-B-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Vascular endothelial growth factor expression is increased in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Antiangiogenic activity of the cleaved conformation of the serpin antithrombin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Angiopoietin-2 and rat brain capillary remodeling during adaptation and deadaptation to prolonged mild hypoxia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Vascular endothelial growth factor-B and retinal vascular development in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Colorectal cancer and nonsteroidal anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Essential role of growth hormone in ischemia-induced retinal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Increased vascularization in mice overexpressing angiopoietin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Topical nepafenac inhibits ocular neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Angiopoietin-1 protects the adult vasculature against plasma leakage.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Retinal astrocytes are immigrants from the optic nerve

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Host cyclooxygenase-2 modulates carcinoma growth.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

The interaction with tubulin of a series of stilbenes based on combretastatin A-4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Serum growth hormone levels and the response of diabetic retinopathy to pituitary ablation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Cell injury unmasks a latent proangiogenic phenotype in mice with increased expression of FGF2 in the retina

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206773

7 January 2021

Identifiers

DOI

1 reference

8 August 2017

1 reference